Zealand Pharma A/S (ZLDPF)
33.88
-0.62
(-1.80%)
USD |
OTCM |
Oct 23, 16:00
Zealand Pharma Market Cap : 2.365B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.365B |
| October 22, 2026 | 2.409B |
| October 21, 2026 | 2.409B |
| October 20, 2026 | 2.372B |
| October 19, 2026 | 2.331B |
| October 16, 2026 | 2.374B |
| October 15, 2026 | 2.374B |
| October 14, 2026 | 2.385B |
| October 13, 2026 | 2.434B |
| October 12, 2026 | 2.434B |
| October 09, 2026 | 2.489B |
| October 08, 2026 | 2.621B |
| October 07, 2026 | 2.621B |
| October 06, 2026 | 2.661B |
| October 05, 2026 | 2.793B |
| October 02, 2026 | 2.793B |
| October 01, 2026 | 2.660B |
| September 30, 2026 | 3.048B |
| September 29, 2026 | 2.932B |
| September 28, 2026 | 2.932B |
| September 25, 2026 | 2.932B |
| September 24, 2026 | 2.932B |
| September 23, 2026 | 3.009B |
| September 22, 2026 | 3.009B |
| September 21, 2026 | 3.002B |
| Date | Value |
|---|---|
| September 18, 2026 | 3.002B |
| September 17, 2026 | 3.002B |
| September 16, 2026 | 3.002B |
| September 15, 2026 | 3.002B |
| September 14, 2026 | 3.002B |
| September 11, 2026 | 3.238B |
| September 10, 2026 | 3.238B |
| September 09, 2026 | 3.238B |
| September 08, 2026 | 3.238B |
| September 04, 2026 | 3.326B |
| September 03, 2026 | 3.326B |
| September 02, 2026 | 3.302B |
| September 01, 2026 | 3.302B |
| August 31, 2026 | 3.252B |
| August 28, 2026 | 3.441B |
| August 27, 2026 | 3.441B |
| August 26, 2026 | 3.617B |
| August 25, 2026 | 3.617B |
| August 24, 2026 | 3.368B |
| August 21, 2026 | 3.526B |
| August 20, 2026 | 3.491B |
| August 19, 2026 | 3.491B |
| August 18, 2026 | 3.426B |
| August 17, 2026 | 3.426B |
| August 14, 2026 | 3.678B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Genmab A/S | 26.14B |
| Ascendis Pharma A/S | 15.98B |
| Bavarian Nordic A/S | 2.798B |
| Evaxion AS | 31.36M |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
Market Cap Related Metrics
| PE Ratio | 5.648 |
| PS Ratio | 3.309 |
| Price to Book Value | 0.8591 |
| Price | 33.88 |
| Earnings Yield | 17.71% |
| Operating PE Ratio | 6.566 |
| Normalized PE Ratio | 5.603 |